advertisement

---

Ahmed II 12

Showing records 1 to 12 | Display all abstracts from Ahmed II

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Vold S
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Christakis PG; Kalenak JW
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Ahmed II; Craven ER
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Tsai JC
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Mattox C
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Zurakowski D; Kammer JA
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Stamper R
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Harasymowycz PJ
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Packer M; Brown RH
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Mura JJ; Cantor LB
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Ianchulev T;
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Ahmed II
Ophthalmology 2016; 123: 2093-2102

---